EUVIMEDEUVIMED entdecken
Crossref

Therapeutic effect of novel antimicrobial peptide Z-d14CFR against multidrug-resistant Escherichia coli-induced endometritis: roles in inflammation Mitigation and endometrial repair

Xue Wang, Siyu Wang, Hao Yang, Qiang Shan, Jieru Xu, Jiufeng Wang, Yaohong Zhu

International Immunopharmacology · 2026-10 · 186 · 117166

DOI: 10.1016/j.intimp.2026.117166 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-10. Verfasst von Xue Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, China Agricultural University, Beijing 100193, China; College of Veterinary Medicine, Inner Mongolia Agricultural Uni…. Hauptthemen laut MEDLINE: Endometritis, Escherichia coli, Escherichia coli Infections, Endometrium. Die Arbeit nennt 49 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometritis is a significant disease in dairy cows that is closely associated with reproductive efficiency. Escherichia coli (E. coli) is one of the primary pathogens leading to endometritis. Over the past few decades, traditional antibiotics have served as the primary therapeutic option for bovine endometritis management. However, the widespread prevalence of antibiotic resistance emphasizes the necessity of alternative development. Our previous study demonstrated that Z-d14CFR, a novel antimicrobial peptide derived from Zophobas atratus defensin, exhibits favorable antimicrobial activity in vitro. Herein, we established bovine endometrial epithelial cell (BEEC) and murine models of endometritis induced by multidrug-resistant (MDR) E. coli. To evaluate the therapeutic effect of Z-d14CFR and explore its underlying molecular mechanism. Our results showed that Z-d14CFR treatment significantly reduced the adhesion of E. coli to BEECs, promoted bacterial clearance in the uterus, and then downregulated the expression of pro-inflammatory cytokines (IL-6, IL-1β, and TNF-α) and upregulated the expression of anti-inflammatory cytokine (IL-10) via inhibiting the TLR4/MyD88/NF-κB signaling pathway activation. In addition, Z-d14CFR increased the expression of tight junction proteins (ZO-1, Occludin, and Claudin-1) suppressed by E. coli, restored endometrial barrier integrity, which further blocked persistent stimulation of E. coli and alleviated endometritis. Moreover, Z-d14CFR increased the expression of regeneration-related cytokines MMP-2 and VEGF-A, reduced excessive collagen deposition, and facilitated neoangiogenesis in the uterine stroma, thereby promoting endometrial repair. Collectively, our findings suggested that Z-d14CFR is a promising candidate for the treatment of endometritis induced by MDR E. coli.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometritisEscherichia coliEscherichia coli InfectionsEndometriumAntimicrobial PeptidesAnti-Bacterial AgentsAnimalsFemaleCattleCytokinesDrug Resistance, Multiple, BacterialToll-Like Receptor 4Epithelial CellsMyeloid Differentiation Factor 88NF-kappa BMiceSignal TransductionCell LineBacterial Adhesion

Stichwörter der Autor:innen

Antimicrobial peptideEndometritisMultidrug-resistance Escherichia coliTLR4/MyD88/NF-κB signaling pathwayTight junction

Substanzen

CytokinesToll-Like Receptor 4Myeloid Differentiation Factor 88NF-kappa BAntimicrobial PeptidesAnti-Bacterial Agents

Autor:innen und Institutionen

  • College of Veterinary Medicine, China Agricultural University, Beijing 100193, China; College of Veterinary Medicine, Inner Mongolia Agricultural University, Hohhot 010018, China. Electronic address: Xue_WANG@imau.edu.c…
  • College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • College of Veterinary Medicine, Northeast Agricultural University, Harbin 150001, China.
  • College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Electronic address: zhu_yaohong@hotmail.com.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Wang, X., Wang, S., Yang, H., Shan, Q., Xu, J., Wang, J., & Zhu, Y. (2026). Therapeutic effect of novel antimicrobial peptide Z-d14CFR against multidrug-resistant Escherichia coli-induced endometritis: roles in inflammation Mitigation and endometrial repair. International Immunopharmacology, 186, 117166. https://doi.org/10.1016/j.intimp.2026.117166

Vancouver

Wang X, Wang S, Yang H, Shan Q, Xu J, Wang J, et al. Therapeutic effect of novel antimicrobial peptide Z-d14CFR against multidrug-resistant Escherichia coli-induced endometritis: roles in inflammation Mitigation and endometrial repair. International Immunopharmacology. 2026;186:117166. doi:10.1016/j.intimp.2026.117166

BibTeX
@article{Wang2026,
  author = {Wang, Xue and Wang, Siyu and Yang, Hao and Shan, Qiang and Xu, Jieru and Wang, Jiufeng and Zhu, Yaohong},
  title = {Therapeutic effect of novel antimicrobial peptide Z-d14CFR against multidrug-resistant Escherichia coli-induced endometritis: roles in inflammation Mitigation and endometrial repair},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {186},
  pages = {117166},
  doi = {10.1016/j.intimp.2026.117166}
}
Kostenlos starten →